Signaling pathways
-
BA6661 EtifoxineSummary: Etifoxine is a non-benzodiazepine, GABAergic compound that is a positive modifier of the receptor subunits α1β2γ2 and α1β3γ2. - BA6662 AfloqualoneSummary: Afloqualone (HQ-495) is a GABAergic reagent with agonist activity on the β-subtype of the
- BA6666 MRK-016Summary: MRK-016 is a selective, orally available, antagonist that crosses the blood-brain barrier.
- BA6667 KavainSummary: Kavain is a class of kavalactones with anxiolytic effects in animals and humans.
- BA6669 BPDBASummary: BPDBA is a selective and noncompetitive inhibitor of the betaine/GABA transporter.
- BA6670 CirsimaritinSummary: Cirsimaritin weakly targets the benzodiazepine site on the binding receptor.
- BA6671 ArecaidineSummary: Arecaidine, a pyridine alkaloid, is a potent absorption inhibitor.
- BA6672 ONO-8590580Summary: Negative deformation modifiers.
- BA6673 DAA-1106Summary: DAA1106 is a peripheral benzodiazepine receptor (PBR) agonist.
- BA6674 AlogabatSummary: Positive allosteric modulator (PAM) of the receptor.